THE Therapeutic Goods Administration (TGA) is pursuing Peptide Clinics Australia for breaches of the Therapeutic Goods Act 1989 around advertising of prescription-only products.
The alleged breaches relate to inappropriate online advertisements for 'peptides' and other prescription-only products.
Proceedings commenced in Dec last year (PD 17 Dec 2018).
The TGA reminds advertisers that in Australia, advertisements for medicines and other types of therapeutic goods must not be misleading and they must not advertise prescription-only medicines to the public.
Peptide Clinics Australia has been liquidated, effective Mar this year, but the Federal Court has granted leave to the Secretary of the Department of Health to continue court proceedings.
The Federal Court hearing is scheduled for 24 Jun 2019.
The above article was sent to subscribers in Pharmacy Daily's issue from 21 May 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 May 19
